Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002214
Filing Date
2008-03-04
Accepted
2008-03-04 16:57:06
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2182823z10-k.htm 10-K 1110221
2 EXHIBIT 10.37 a2182823zex-10_37.htm EX-10.37 10313
3 EXHIBIT 23.1 a2182823zex-23_1.htm EX-23.1 1659
4 EXHIBIT 31.1 a2182823zex-31_1.htm EX-31.1 7672
5 EXHIBIT 31.2 a2182823zex-31_2.htm EX-31.2 7669
6 EXHIBIT 32.1 a2182823zex-32_1.htm EX-32.1 4172
7 EXHIBIT 32.2 a2182823zex-32_2.htm EX-32.2 4168
8 G218356.JPG g218356.jpg GRAPHIC 20668
  Complete submission text file 0001047469-08-002214.txt   1175883
Mailing Address 310 GOLDEN SHORE LONG BEACH CA 90802
Business Address 310 GOLDEN SHORE LONG BEACH CA 90802 562-628-1007
Obagi Medical Products, Inc. (Filer) CIK: 0001375247 (see all company filings)

EIN.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33204 | Film No.: 08664529
SIC: 2834 Pharmaceutical Preparations